Bain & Company August 13, 2025
Reaching new heights takes more than size. It’s about making smarter moves.
In medtech, M&A isn’t optional. It’s a must. Investors reward revenue growth more than productivity gains, making acquisitions an effective way to increase valuation. The real competitive edge, then, lies not in doing M&A, but in doing it well.
That doesn’t simply mean doing bigger deals. In fact, in medtech, large deals don’t guarantee success....







